Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...

Merck & Co. is making waves as an undervalued S&P 500 stock, boasting a forward P/E ratio of 10.52 and strong hedge fund ...

We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look ...

Merck & Co Inc. has become a top contender for the most profitable value stock, but it faces some challenges. Merck boasts a forward P/E ratio of 10.36 and TTM net income of $17.117 billion. Despite ...

We recently published a list of 10 Most Profitable Value Stocks to Buy Now. In this article, we are going to take a look at ...

It’s important to note that Zervos praised Cuggino’s diversified portfolio approach, particularly his use of hedges and fixed ...

The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.

This survey investigates the knowledge, attitudes, and intentions of US Hispanic parents surrounding the HPV vaccine.

Nearly everyone who isn't vaccinated against HPV will be infected at some point, though 9 out of 10 infections resolve within ...

DURHAM, N.C. (WTVD) -- Drugmaker Merck announced Tuesday the opening of a new $1 billion vaccine manufacturing facility in North Durham. The plant will manufacture the HPV vaccines Gardasil and ...

Besides classic tobacco and alcohol risk factors, human papillomavirus (HPV) plays a role in the development of a subset of head and neck squamous cell carcinomas (HNSCCs), and notably oropharynx ...